Diagnostic Pitfalls in Urologic Pathology
September 22 - 23, 2018
Physicians Can Earn A Maximum Of 16 AMA PRA Category 1 Credits™
Physicians Can Earn A Maximum Of 16 SAM Credit Hours
Adeboye O. Osunkoya, MD
Adeboye O. Osunkoya, M.D. is a Professor of Pathology and Urology at Emory University School of Medicine, where he directs the Urologic Pathology service and the Surgical Pathology Fellowship Program. He serves in leadership roles in national and international organizations and is currently an elected member of the Board of Directors of the United States and Canadian Academy of Pathology (USCAP), Director of Urologic Pathology at the USCAP Interactive Center, and Chair of the Excellence in Urological Pathology Resident/Fellow Research Award Committee of the International Society of Urological Pathology. He previously served as Chair of the Stephen Vogel Award Committee of the USCAP (2014-2016), member of the Education Committee of the USCAP (2012-2016), USCAP Ambassador, member of the Stowell-Orbison Award Committee of the USCAP and Abstract Review Committee of the USCAP. He serves on the Editorial Board of well-known Journals including Archives of Pathology and Laboratory Medicine (Section Editor: Urologic Pathology), Human Pathology, International Journal of Clinical and Experimental Pathology and Pathology. Dr. Osunkoya has presented several lectures and conferences in the United States and abroad, including USCAP, European Congress of Pathology, International Academy of Pathology and Asia Pacific International Academy of Pathology meetings. In addition, he was the Director of the Diagnostic Challenges in Prostate Pathology USCAP Short Course (2015-2017) and Director of the Interactive Microscopy Courses on Prostate Pathology in 2015 (Boston and Saint Louis), 2016 (Seattle and Palm Springs), and 2017 (San Antonio). He was an invited speaker at the 2017 USCAP Long Course. Dr. Osunkoya has been involved in several major research grants over the years, and has published over 120 manuscripts, over 20 book chapters, and has won numerous awards including the very prestigious Benjamin Castleman Award (2010) and the highly coveted Arthur Purdy Stout Prize (2015).
Muhammad T. Idrees, M.D., M.B.B.S.
Indiana University School of Medicine
Dr. Idrees is an Associate Professor of Pathology at Indiana University School of Medicine and Director of the immunohistochemistry and molecular laboratory at Indiana University Health Pathology in Indianapolis, Indiana. He received his M.B. B.S. degree from the University of Punjab, Pakistan. He completed his residency in Pathology at the Mount Sinai Medical Center with subsequent fellowships in gynecologic pathology, surgical/urologic pathology and cytopathology, before proceeding to a faculty appointment in urologic pathology at Mount Sinai School of Medicine. He is a Diplomat of the American Board of Pathology in Anatomic and Clinical Pathology with subspecialty certification in cytopathology and focused interest in urologic pathology, especially tumors of testis and para-testis. Since joining the Indiana University in 2008, Dr. Idrees has developed unique expertise in testicular pathology and regularly signs out and consults on challenging and complex cases from all over the nation and world.
Dr. Idrees has more than 70 peer-reviewed publications and numerous contributions to other pathology organizations, journals and online publications. He is a committee member of the upcoming WHO 2016 Classification of the “Tumours of the Urinary System and Male Genital Organs” and author and contributor for ICCR Testis and RPLND data sets. He is credited with various abstracts, presentations and lectures at national and international pathology meetings, and is a speaker at the USCAP short course on testicular pathology. He will also be directing a new USCAP short course for next three years highlighting the numerous changes in classification of testicular neoplasms rectified in WHO 2016 classification. He has lectured for the International Society of Urologic Pathology (ISUP). He has served as general secretory and chairman of continuing medical education for Indiana association of Pathology (IAP) for number of years and currently is the vice president of that society.
Cristina Magi-Galluzzi, M.D., Ph.D.
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Dr. Magi-Galluzzi is the Division Director of Anatomic Pathology and Professor of Pathology at the University of Alabama at Birmingham. She received her MD at the University of Ancona, School of Medicine, Italy and her PhD in Oncologic Human Pathology at the University of Verona, Italy. She completed her residency in Anatomic and Clinical Pathology at Rush University Medical Center in Chicago (1997-1999) and Brigham & Women’s Hospital, Harvard Medical School in Boston (1999-2001), followed by a fellowship in Urologic Pathology at the Johns Hopkins University in Baltimore (2001-2003). She was on staff at the Cleveland Clinic from 2003 to 2018 and Director of Genitourinary pathology from 2004 to 2018.
Her clinical expertise is the pathological diagnosis of genitourinary diseases, including prostate, bladder, testicular, adrenal and kidney malignancies. Her research interest focuses on prostate carcinogenesis and in the discovery and validation of tumor markers and genomic tests of value in furthering the goals of successful treatment and understanding of the pathogenesis of genitourinary disease. She is the author of numerous (~200) peer-reviewed publications, invited reviews and book chapters, as well as the editor of two books on genitourinary pathology. She has presented and lectured extensively at national and international meetings and has conducted national and international courses, workshops and slide seminars in urological pathology.
Dr. Magi-Galluzzi is a member of the USCAP Board of Directors and a board member-at-large of the Arthur Purdy Stout Society (APSS).
Ming Zhou, M.D., Ph.D.
University of Texas Southwestern Medical Center
Dr. Zhou is currently the Dr. Charles T. Ashworth Professor of Pathology and Director of Anatomic Pathology at The University of Texas Southwestern Medical Center in Dallas, Texas.
He graduated summa cum laude from Fudan University Medical School in Shanghai, China. He did his pathology residency training and counted Drs. Sharon Weiss, Henry Appelman and Mark Rubin as his mentors at the University of Michigan, Ann Arbor, Michigan. He completed a fellowship in Urological and Kidney Diseases with Dr. Jonathan Epstein at the Johns Hopkins Hospital. Before he moved to NYU, he was an Associate Professor and staff pathologist at the Cleveland Clinic, Cleveland, Ohio.
He has devoted his clinical and research effort to diagnostic urological pathology, and discovery and validation of tumor markers for urological malignancy. He has authored over 170 research articles and numerous book chapters, and is the editor of 4 textbooks of urological pathology and prostate pathology. He serves on the Cancer Committee of the College of American Pathologists and is the primary author of the genitourinary cancer protocols. He is the treasurer of the International Society of Urological Pathology. He also serves on the editorial board of several pathology journals, including Modern Pathology.